The potential pharma companies see in this type of therapy was demonstrated last year, when Juno signed a decade-long, billion-dollar deal with Celgene to develop CAR-T therapies. Hans Bishop ...

Juno has halted a phase 2 trial of its CAR-T cell therapy after two more patient deaths. The biotech company became the second company to see its shares dive on bad news in the space of a few ...

Here's why. Gett also blamed "the enactment of misguided regulations in New York City earlier this year" for the end of Juno. New NYC regulations for 2019 capped the number of cars each ride ...

Dax Shepard revealed that Sabrina Carpenter’s music has become a staple on their morning car rides. While Shepard enjoys her ...